Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort

被引:32
作者
Bandoli, Gretchen [1 ,2 ]
Palmsten, Kristin [3 ]
Chambers, Christina [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[3] HealthPartners Inst, Minneapolis, MN USA
基金
英国医学研究理事会;
关键词
acetaminophen; indications for use; pregnancy; prevalence; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; THE-COUNTER MEDICATIONS; PARACETAMOL EXPOSURE; POSTNATAL DEPRESSION; RISK; WOMEN;
D O I
10.1111/ppe.12595
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Previous studies of prenatal acetaminophen use have not addressed what indications and maternal co-factors describe acetaminophen use. Objective The objective of this study was to describe these parameters in a well-characterised, prospective birth cohort. Methods Data were drawn from the MotherToBaby study of pregnant women enrolled from 2004 to 2018. Daily acetaminophen diaries were calculated for all exposed women with complete dose and duration information. Descriptive statistics were used to assess maternal characteristics associated with acetaminophen use. Prevalence by 2-year interval was described, and linear regression was used to test for trend. Indication of use and dose per indication were summarised. Results Of 2441 subjects, 1515 (62%) reported use of acetaminophen. Over the 15-year period, there was a decline in use of 2.5% for each 2-year period (test for trend = 0.001) with 58% reporting acetaminophen use in 2017-2018. Among women with acetaminophen use in pregnancy (n = 1515), 58% reported <10 days of use, 13% reported 10-19 days of use, 9% reported 20-44 days of use, and 9% reported 45 or more days of use. Twelve per cent had undefined duration of use. Increasing duration of exposure was associated with tobacco use, obesity, self-reported depression or anxiety, and antidepressant use. The most frequently reported indication was headache, however, indication varied by duration of use, with more women reporting use for sleep or pain/injury in the categories with the longest duration of use. Median dose per exposed day was highest among those reporting use for sleep, and higher doses were more frequently reported for arthritis, injury, and pain. Conclusion Acetaminophen is used by the majority of pregnant women, and some continue to use for many weeks in pregnancy. Given the heterogeneity in duration of use, indication, and dose, studies that estimate the risk of adverse outcomes associated with acetaminophen must carefully consider these factors.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 50 条
  • [41] Prevalence and predictors of anal incontinence during pregnancy and 1 year after delivery: a prospective cohort study
    Johannessen, H. H.
    Wibe, A.
    Stordahl, A.
    Sandvik, L.
    Backe, B.
    Morkved, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 (03) : 269 - 280
  • [42] Herbal products use during pregnancy: prevalence and predictors
    Moussally, Krystel
    Oraichi, Driss
    Berard, Anick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (06) : 454 - 461
  • [43] Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study
    Zhang, Yin
    Chan, Andrew T.
    Meyerhardt, Jeffrey A.
    Giovannucci, Edward L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 841 - 851
  • [44] Physical activity during pregnancy and adverse birth outcome: a prospective cohort study in China
    Li, Jinxiu
    Huang, Dongping
    Liang, Jun
    Chen, Jiehua
    Lei, Lei
    Lin, Mengrui
    Wu, Kaili
    Xiao, Suyang
    Lai, Mingshuang
    Qiu, Xiaoqiang
    Qian, Zhengmin
    Vaughn, Michael G.
    McMillin, Stephen Edward
    Dong, GuangHui
    Zeng, Xiaoyun
    Liu, Shun
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (01)
  • [45] Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study
    Viktorin, Alexander
    Levine, Stephen Z.
    Altemus, Margret
    Reichenberg, Abraham
    Sandin, Sven
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [46] Opium use during pregnancy and infant size at birth: a cohort study
    Siavash Maghsoudlou
    Sven Cnattingius
    Scott Montgomery
    Mohsen Aarabi
    Shahriar Semnani
    Anna-Karin Wikström
    Shahram Bahmanyar
    BMC Pregnancy and Childbirth, 18
  • [47] Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort
    Lemelin, Maxim
    Boukhris, Takoua
    Zhao, Jin-Ping
    Sheehy, Odile
    Berard, Anick
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03):
  • [48] Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study
    Richardson, J. L.
    Martin, F.
    Dunstan, H.
    Greenall, A.
    Stephensa, S.
    Yates, L. M.
    Thomas, S. H. L.
    REPRODUCTIVE TOXICOLOGY, 2019, 84 : 108 - 113
  • [49] Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study
    McInerney, Kathryn A.
    Hatch, Elizabeth E.
    Wesselink, Amelia K.
    Rothman, Kenneth J.
    Mikkelsen, Ellen M.
    Wise, Lauren A.
    HUMAN REPRODUCTION, 2017, 32 (01) : 103 - 111
  • [50] Association between paracetamol use during pregnancy and perinatal outcomes: Prospective NISAMI cohort
    de Castro, Caroline Tianeze
    Pereira, Marcos
    dos Santos, Djanilson Barbosa
    PLOS ONE, 2022, 17 (04):